INVO Fertility annual r&d spending
2019
2020
2021
2022
2023
2024
2025
INVO Fertility R&D Spending Growth & History (IVF)
INVO Fertility's r&d spending was $0 for fiscal 2025.
View full INVO Fertility company overviewINVO Fertility annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0 | −$4,880 | — |
| 2024 | 2024-12-31 | $4,880 | −$161,065 | −97.06% |
| 2023 | 2023-12-31 | $165,945 | −$378,098 | −69.50% |
| 2022 | 2022-12-31 | $544,043 | $327,613 | +151.37% |
| 2021 | 2021-12-31 | $216,430 | −$181,996 | −45.68% |
| 2020 | 2020-12-31 | $398,426 | $398,426 | — |
| 2019 | 2019-12-31 | $0 | — | — |
INVO Fertility quarterly r&d spending
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $0 | $0 | — |
| Q3 2025 | 2025-09-30 | $0 | $0 | — |
| Q2 2025 | 2025-06-30 | $0 | $0 | — |
| Q1 2025 | 2025-03-31 | $265,663 | $260,783 | +5343.91% |
| Q4 2024 | 2024-12-31 | $0 | −$5,907 | — |
| Q3 2024 | 2024-09-30 | $0 | −$2,668 | — |
| Q2 2024 | 2024-06-30 | $0 | −$83,850 | — |
| Q1 2024 | 2024-03-31 | $4,880 | −$68,640 | −93.36% |
| Q4 2023 | 2023-12-31 | $5,907 | −$67,928 | −92.00% |
| Q3 2023 | 2023-09-30 | $2,668 | −$172,599 | −98.48% |
| Q2 2023 | 2023-06-30 | $83,850 | −$106,911 | −56.04% |
| Q1 2023 | 2023-03-31 | $73,520 | −$30,660 | −29.43% |
| Q4 2022 | 2022-12-31 | $73,835 | $10,079 | +15.81% |
| Q3 2022 | 2022-09-30 | $175,267 | $119,876 | +216.42% |
| Q2 2022 | 2022-06-30 | $190,761 | $159,745 | +515.04% |
| Q1 2022 | 2022-03-31 | $104,180 | $37,913 | +57.21% |
| Q4 2021 | 2021-12-31 | $63,756 | −$157,178 | −71.14% |
| Q3 2021 | 2021-09-30 | $55,391 | −$57,161 | −50.79% |
| Q2 2021 | 2021-06-30 | $31,016 | −$3,874 | −11.10% |
| Q1 2021 | 2021-03-31 | $66,267 | $36,217 | +120.52% |
| Q4 2020 | 2020-12-31 | $220,934 | $220,934 | — |
| Q3 2020 | 2020-09-30 | $112,552 | $112,552 | — |
| Q2 2020 | 2020-06-30 | $34,890 | $34,890 | — |
| Q1 2020 | 2020-03-31 | $30,050 | $30,050 | — |
| Q4 2019 | 2019-12-31 | $0 | — | — |
| Q3 2019 | 2019-09-30 | $0 | — | — |
| Q2 2019 | 2019-06-30 | $0 | — | — |
| Q1 2019 | 2019-03-31 | $0 | — | — |
INVO Fertility r&d spending trends
Over the last five fiscal years, INVO Fertility's r&d spending decreased from $398,426 to $0, a change of −$398,426. The latest reported quarter, Q4 2025, shows $0.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review INVO Fertility source filings ↗